Wednesday, July 8, 2026

pharma · Melanoma · Ovarian Cancer

Sandoz (Japan)

Sandoz (Japan) trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Basel, CH HQ
17,495 Employees
TGA registrant Type
Company details
Status
Public
HQ
Basel, CH
Employees
17,495
Programs
4
Drugs
22
Patents
0
Intelligence · Clinical Trials

Sandoz (Japan) clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to Sandoz (Japan) programs — each row shows trial ID, program name, phase, status, and indication.

Sandoz (Japan) trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Sandoz (Japan).

  1. SAN-1138 — Phase 3

    Clinical update
  2. Olaparib tablets, 150 mg — Phase 1

    Clinical update
  3. JPB898 (Induction and Maintenance) — Phase 3

    Clinical update
  4. GME751 — Phase 1

    Clinical update

Trial registry

4 studies